Celcuity Inc. (CELC) intrinsic value & 10-year financials

Celcuity Inc. (CELC) has no Graham intrinsic value right now because the formula needs positive earnings.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$56.58
Market cap
$2.6B
Revenue (FY2025)
—
ROIC (10-yr avg)
-1303.5%
Free cash flow (FY2025)
-$153.5M

CELC 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 — -$177.0M -$3.79 -$153.5M — -130.8%
FY2024 — -$111.8M -$2.83 -$83.7M — -64.8%
FY2023 — -$63.8M -$2.69 -$53.9M — -43.7%
FY2022 — -$40.4M -$2.64 -$36.2M — -55.5%
FY2021 — -$29.6M — -$20.4M — -9920.7%
FY2020 — -$9.5M — -$7.2M — -2488.6%
FY2019 — -$7.4M — -$6.4M — -155.2%
FY2018 — -$7.5M — -$6.7M — -84.2%
FY2017 — -$6.3M — -$5.2M — -32.2%
FY2016 — -$3.3M — -$2.9M — -59.3%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Celcuity Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Celcuity Inc. has historically struggled to out-earn its cost of capital, averaging just -59.6% ROIC.

Celcuity Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Celcuity Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.

CELC stock: frequently asked questions

What is the intrinsic value of Celcuity Inc. (CELC) stock?

Graham's formula only works with positive earnings. Celcuity Inc. reported diluted EPS of -$3.79 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Celcuity Inc. generate free cash flow?

Celcuity Inc. generated -$153.5M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 10 reported years.

What is CELC's return on invested capital?

Average ROIC over the last 10 fiscal years was -1303.5%, and average return on equity was -62.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this CELC data come from?

From Celcuity Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 14, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medical laboratories stocks